Open for inclusion

Dose-escalating safety trial of tissue factor specific antibody drug conjugate (Humax®-TF-ADC) in patients with locally advanced and/or metastatic solid tumors known to express tissue factor

Cancer type: Solide tumores

Phase: I

Principal Investigator: Lassen Ulrik

Country: DK

Keywords: Denmark, Rigshospitalet, TF-ADC

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02552121?term=GEN702&rank=1